AU6167599A - Use of a beta2 adrenergic receptor agonist in the treatment of cardiovascular disease - Google Patents

Use of a beta2 adrenergic receptor agonist in the treatment of cardiovascular disease

Info

Publication number
AU6167599A
AU6167599A AU61675/99A AU6167599A AU6167599A AU 6167599 A AU6167599 A AU 6167599A AU 61675/99 A AU61675/99 A AU 61675/99A AU 6167599 A AU6167599 A AU 6167599A AU 6167599 A AU6167599 A AU 6167599A
Authority
AU
Australia
Prior art keywords
treatment
cardiovascular disease
receptor agonist
adrenergic receptor
beta2 adrenergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61675/99A
Inventor
Heping Cheng
Edward G. Lakatta
Rui-Ping Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU6167599A publication Critical patent/AU6167599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
AU61675/99A 1998-09-30 1999-09-30 Use of a beta2 adrenergic receptor agonist in the treatment of cardiovascular disease Abandoned AU6167599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10247598P 1998-09-30 1998-09-30
US60102475 1998-09-30
PCT/US1999/022712 WO2000018389A2 (en) 1998-09-30 1999-09-30 USE OF A β2 ADRENERGIC RECEPTOR AGONIST IN THE TREATMENT OF CARDIOVASCULAR DISEASE

Publications (1)

Publication Number Publication Date
AU6167599A true AU6167599A (en) 2000-04-17

Family

ID=22290059

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61675/99A Abandoned AU6167599A (en) 1998-09-30 1999-09-30 Use of a beta2 adrenergic receptor agonist in the treatment of cardiovascular disease

Country Status (2)

Country Link
AU (1) AU6167599A (en)
WO (1) WO2000018389A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007533668A (en) * 2004-04-23 2007-11-22 ノーザン シドニー アンド セントラル コースト エリア ヘルス サービス Methods and compositions for treating myocardial disease
CA2660707C (en) 2006-08-10 2014-07-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
EP2544676B1 (en) 2010-03-10 2018-09-19 The United States of America, as represented by The Secretary, Department of Health and Human Services The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
EP3720445A4 (en) 2017-12-04 2021-08-18 The Board of Trustees of the Leland Stanford Junior University Beta-2 selective adrenergic receptor agonists

Also Published As

Publication number Publication date
WO2000018389A3 (en) 2000-11-16
WO2000018389A2 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
AU2171500A (en) Ambulatory apnea screening device
AU4552099A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT2 receptors
AU6418600A (en) Medical device with time-out feature
TW404638U (en) Plane monitor used foot seat
AU6405300A (en) Chronic disease monitor
EP0789570A4 (en) Oral hypoglycemic agents
IL137990A0 (en) A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
AU1926000A (en) Pth1r and pth3r receptors
AU775774C (en) Peroxisome proliferator-activated receptor agonist
AUPP714398A0 (en) Slip & slip resistant furniture foot device slipstick foot
AU7791800A (en) Blade holder for a doctor and a method for using the doctor
GB9802599D0 (en) Medical use
AU6043600A (en) Use of an angiotensin ii type 1 receptor antagonist in the manufacture of a medicament for the treatment of cardiovascular complications
AU1744700A (en) Human neurotensin subtype 2 receptor
AU6167599A (en) Use of a beta2 adrenergic receptor agonist in the treatment of cardiovascular disease
AU2568600A (en) Apparatus and method for massaging a user's back
EP1372690A4 (en) 93870, a human g-protein coupled receptor and uses therefor
AU3344499A (en) Hypoglycemic agents
AU137818S (en) Dispenser for dental floss and the like
FR2800589B1 (en) ARTICULATED ARMCHAIR FOR MEDICAL USE, FOR THE DISABLED AND FOR RELAXATION
SG83688A1 (en) A chair
GB2337050B (en) Fullerene-containing metallocene
AU2288801A (en) 2871 receptor, a g-protein coupled receptor and methods of use thereof
AU6079000A (en) Developed seed and methods for making the same
AU693070B3 (en) Sitting pad

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase